It has been reported that IL-2 mutein can ameliorate pathological inflammation in a DSS-induced but not T-cell transfer colitis model, because IL-2Rα+CD8+ T cells exist in large amount in inflammatory lesions in the latter model23. This evidence concerns the gene CD8A and colitis.